Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 6/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.69 |
| ▸ | USP2 | O75604 | 2/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.69 |
| ▸ | PDE5A | O76074 | 5/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.56 |
| ▸ | ATM | Q13315 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.56 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.56 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.51 |
| ▸ | MAOA | P21397 | 1/20 | 0.51 |
| ▸ | MAOB | P27338 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5392688 | 0.80 | MEN1 (1.00) | MEN1KMT2AUSP2TDP1L3MBTL1 | |
| SCHEMBL12495092 | 0.78 | PDE5A (1.00) | PDE5AL3MBTL1ATMGLA | |
| SCHEMBL16740616 | 0.76 | PRKCZ (0.73) | MEN1KMT2APDE5AHSP90AA1MAOA | |
| SCHEMBL27778740 | 0.76 | PDE5A (0.57) | MEN1KMT2ATDP1PDE5AL3MBTL1 | |
| SCHEMBL5403178 | 0.76 | MEN1 (0.90) | MEN1KMT2AUSP2TDP1PDE5A | |
| SCHEMBL18826385 | 0.75 | L3MBTL1 (0.80) | KMT2APDE5AL3MBTL1ATMALDH1A1 | |
| SCHEMBL5406698 | 0.75 | MEN1 (0.63) | MEN1KMT2AUSP2TDP1L3MBTL1 | |
| SCHEMBL16740622 | 0.74 | CA1 (0.63) | MEN1KMT2ATDP1PDE5AL3MBTL1 | |
| SCHEMBL27953563 | 0.73 | KMT2A (0.57) | MEN1KMT2ATDP1PDE5AL3MBTL1 | |
| SCHEMBL5402963 | 0.72 | PDE5A (0.46) | MEN1KMT2AUSP2TDP1PDE5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7211335-B2 | Red organic light-emitting compound and organic light-emitting device comprising the same | NEOVIEWKOLON CO., LTD. (KR) | 2007-05-01 | — | — | US | disclosed |
| US-7211335-B2 | Red organic light-emitting compound and organic light-emitting device comprising the same | NEOVIEWKOLON CO., LTD. (KR) | 2007-05-01 | — | — | US | disclosed |
| US-20060022584-A1 | Dicyanomethylidene-substituted pyrans, thiopyrans, dihydropyridines, or cyclohexadienes, containing amino- or pyrazolonyl- thiophene groups or pyrazolonophenyl groups; superior heat-resistance and stability | NEOVIEWKOLON CO., LTD. (KR) | 2006-02-02 | — | — | US | disclosed |
| WO-2003078542-A1 | RED ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME | NEOVIEW CO., LTD. (KR) | 2003-09-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060022584-A1 | Dicyanomethylidene-substituted pyrans, thiopyrans, dihydropyridines, or cyclohexadienes, containing amino- or pyrazolonyl- thiophene groups or pyrazolonophenyl groups; superior heat-resistance and stability | CBR3, CBR1, TDO2 | MEN1 4475/4885KMT2A 2881/4885USP2 4275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.